Enzyme replacement in Gaucher disease.
Beutler
Ernest
E
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California, USA. beutler@scripps.edu
D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005776:Gaucher Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D005962:Glucosylceramidase / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D037181:Lectins, C-Type; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins; D018579:Patient Selection; D011956:Receptors, Cell Surface; D016896:Treatment Outcome
D037181:Lectins, C-Type; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins; D011956:Receptors, Cell Surface; D005962:Glucosylceramidase